NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2025
Voltar para busca
Dado oficial do USPTO
KNOW HYPOPARA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
09/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 41, 44
Data de depósito
14/06/2023
Data de registro
09/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/12/2025
Última transação
09/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
Hellerup, DK
Examinador
TWAY, TATIANA R
Unidade examinadora
L50
Localização atual
INTENT TO USE SECTION
Descrição da marca
The mark consists of the wording "KNOW HYPOPARA" in blue text with the word "KNOW" inside a yellow shaded circle.
Titulares e representantes
Titulares
Ascendis Pharma Endocrinology Division A/S
Representantes
Shannon Marie McKeon DYKEMA GOSSETT PLLC
Classificação técnica
Classes Nice
Classe 9Classe 41Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software and downloadable computer application software for use in providing medical advice and advice on medications for treatmentpatient assistance and health insurance in the field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for sharing information related to hypoparathyroidismgrowth disordersendocrine disorders and bone disorders and the treatment of hypoparathyroidismgrowth disordersendocrine disordersbone disorders for use by patients with growth hormone disordershypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders
Classe 41
Educational and teaching servicesproviding conferencessymposiumsseminarsworkshopslecturesclasses and online education seminars in the field of pharmaceuticalsmedicinehealth care; Publication of non-downloadable electronic publications in the nature of advisory board reportsmagazinesjournals and articles in the field of pharmaceuticalmedical and healthcare topics; Editorial reporting services; News syndication reporting; Educational servicesconducting educational programs for patients and healthcare providers related to hypoparathyroidismgrowth disordersendocrine disorders and bone disorders and the treatment of hypoparathyroidismgrowth disordersendocrine disordersbone disorders for use by patients with growth hormone disordershypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders
Classe 44
Providing and sharing of medical information and advice relating to growth hormone deficiencyendocrinological disordersbone and skeletal disordersdiagnosis and treatmentmedical screeningmedicinehealth and pharmaceutical products; Patient support programproviding health care information to patients and healthcare providers in the field of growth hormone deficiencyendocrine disordersbone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; Providing an online website featuring medical and healthcare information related to hypoparathyroidismgrowth disordersendocrine disorders and bone disorders and the treatment of hypoparathyroidismgrowth disordersendocrine disordersbone disorders for use by patients with growth hormone disordershypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
14/11/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/11/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/07/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
02/07/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2024
PUBO
PUBLISHED FOR OPPOSITION
10/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/11/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/10/2024
GNFR
FINAL REFUSAL E-MAILED
21/10/2024
CNFR
FINAL REFUSAL WRITTEN
21/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/09/2024
ALIE
ASSIGNED TO LIE
26/09/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
30/05/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
29/05/2024
GNSL
LETTER OF SUSPENSION E-MAILED
29/05/2024
CNSL
SUSPENSION LETTER WRITTEN
29/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/05/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/02/2024
GNRT
NON-FINAL ACTION E-MAILED
21/02/2024
CNRT
NON-FINAL ACTION WRITTEN
21/02/2024
DOCK
ASSIGNED TO EXAMINER
14/02/2024
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
19/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/07/2023
NWAP
NEW APPLICATION ENTERED
17/06/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KNOW HYPOPARA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.